Form D · Biotechnology

ACESIS HOLDINGS CORP.

Lone Tree, CO · CIK 0001955728

Offering snapshot reported Jun 9, 2023 · SEC filing

Reported sold
$1.36M
Offering amount: $1.5M
Investors reported
15
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Dec 27, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$680K$1.36MJan 11, 2023: $250,000.00Jan 11, 2023Mar 1, 2023: $935,000.00Mar 1, 2023Apr 7, 2023: $1,260,000.00Apr 7, 2023Jun 9, 2023: $1,360,000.00Jun 9, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,260,000 → $1,360,000
  • Reported investors14 → 15

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 9, 2023Amendment$1,360,000$100,000vs Apr 7, 202315SEC filing
Apr 7, 2023Amendment$1,260,000$325,000vs Mar 1, 202314SEC filing
Mar 1, 2023Amendment$935,000$685,000vs Jan 11, 202312SEC filing
Jan 11, 2023Initial$250,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$109K (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-470295
In addition to cash rewards, the Placement Agent received warrants to purchase 95,200 shares of common stock.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
BOUSTEAD SECURITIES, LLC141391

Source: Form D, filed Jun 9, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Costas N Karatzas Executive
Konstantinos N Karatzas Director, Executive
Duane Charles Knight Executive
Thomas B Olson Executive
Vassilios Papadopoulos Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
9233 Park Meadows Drive Suite 108
Lone Tree, CO, 80124